Cohance Lifesciences Limited — Updates, 23-07-2026: General Updates
23-07-2026 | 09:27 pm
23-07-2026 | 09:27 pm
Cohance Lifesciences approved significant employee stock options: up to 1.97 Cr under ESOP 2026, and 0.017 Cr under ESOP 2023. It allotted 30,190 shares from exercised options and cancelled 0.018 Cr previous ESOP 2023 grants, plus 1.79 Cr voluntarily surrendered options.
No comments yet. Be the first to comment!
